The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution
Open accessAbstract
This randomized, controlled trial assessed the effect of transarterial embolization (TAE) (without associated chemotherapy) on the survival of patients with nonsurgical hepatocellular carcinoma (HCC). Eighty consecutive patients were randomized to treatment with embolization (Group A, n = 40), or to symptomatic treatment (Group B, n = 40), there being no differences between both groups regarding the degree of liver function impairment and tumor stage. Eighty-two percent of the patients presented a self-limited postembolization syndrome, without treatment-related mortality. Fifty-five percent of the treated cases exhibited a partial response, which resulted in a lower probability of tumor progression during follow-up (57% vs. 77% at 1 year; P < .005). However, after a median follow-up of 24 months (30 deaths in each group), there are no differences in survival (Group A: 49% and 13%; Group B: 50% and 27%, at 2 and 4 years, respectively; P = .72). The absence of differences was maintained even when dividing patients according to Child-Pugh’s grade, Okuda stage, or performance status test (PST). Furthermore, there were no differences in the probability of complications or in the need of hospital admissions. In conclusion, TAE has a marked antitumoral effect associated to a slower growth of the tumor, but it does not improve the survival of patients with nonsurgical HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
Okuda, K., Ohtsuki, T., Obata, H., Tomimatsu, M., Okazaki, N., Hasegawa, H., Nakajima, Y., & Ohnishi, K. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e · Cited by 1,931
Bruix, J., Castells, A., Bosch, J., Feu, F., Fuster, J., Garcia-Pagan, J., Visa, J., Bru, C., & Rodes, J. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70070-7 · Cited by 895
Self-citation(1995) · New England Journal of Medicine · doi:10.1056/nejm199505113321903 · Cited by 809
Harris, C. C. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1442 · Cited by 680
Performance status assessment in cancer patients. An inter-observer variability study
Sørensen, J., Klee, M., Palshof, T., & Hansen, H. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.140 · Cited by 483
Pelletier, G., Roche, A., Ink, O., Anciaux, M. L., Derhy, S., Rougier, P., Lenoir, C., Attali, P., & Etienne, J.-P. (1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90110-d · Cited by 417
Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
Simonetti, R. G., Liberati, A., Angiolini, C., & Pagliaro, L. (1997) · Annals of Oncology · doi:10.1023/a:1008285123736 · Cited by 380
Castells, A., Bruix, J., Bru, C., Fuster, J., Vilana, R., Navasa, M., Ayuso, C., Boix, L., Visa, J., & Rodés, J. (1993) · Hepatology · doi:10.1002/hep.1840180517 · Cited by 368
Self-citationTreatment of Hepatocellular Carcinoma
Bruix, J. (1997) · Hepatology · doi:10.1002/hep.510250201 · Cited by 277
Self-citationPrimary treatment of hepatocellular carcinoma by arterial chemoembolization
Bismuth, H., Morino, M., Sherlock, D., Castaing, D., Miglietta, C., Cauquil, P., & Roche, A. (1992) · The American Journal of Surgery · doi:10.1016/0002-9610(92)90039-t · Cited by 260
Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patients
Calvet, X., Bruix, J., Ginés, P., Bru, C., Sole, M., Vilana, R., & Rodés, J. (1990) · Hepatology · doi:10.1002/hep.1840120422 · Cited by 226
Self-citationIkeda, K., Kumada, H., Saitoh, S., Arase, Y., & Chayama, K. (1991) · Cancer · doi:10.1002/1097-0142(19911115)68:10<2150::aid-cncr2820681011>3.0.co;2-f · Cited by 212
Castells, A., Bruix, J., Brú, C., Ayuso, C., Roca, M., Boix, L., Vilana, R., & Rodés, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90402-6 · Cited by 187
Self-citationMondazzi, L., Bottelli, R., Brambilla, G., Rampoldi, A., Rezakovic, I., Zavaglia, C., Alberti, A., & Idèo, G. (1994) · Hepatology · doi:10.1002/hep.1840190508 · Cited by 172
Arroyo, V., Ginès, P., Rimola, A., & Gaya, J. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90912-5 · Cited by 140
Vetter, D., Wenger, J.-J., Bergier, J.-M., Doffoël, M., & Bockel, R. (1991) · Hepatology · doi:10.1002/hep.1840130308 · Cited by 124
Stuart, K. E., Stokes, K., Jenkins, R. L., Trey, C., & Clouse, M. E. (1993) · Cancer · doi:10.1002/1097-0142(19931201)72:11<3202::aid-cncr2820721112>3.0.co;2-4 · Cited by 93
Louha, M., Poussin, K., Ganne‐Carrié, N., Zylberberg, H., Nalpas, B., Nicolet, J., Capron, F., Soubrane, O., Vons, C., Pol, S., et al. (1997) · Hepatology · doi:10.1002/hep.510260430 · Cited by 78
Arora, A. S., de Groen, P. C., Croall, D. E., Emori, Y., & Gores, G. J. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199606)167:3<434::aid-jcp7>3.0.co;2-q · Cited by 53
Jia, L., Wang, X. W., Sun, Z., & Harris, C. C. (1997) · Springer eBooks · doi:10.1007/978-4-431-65915-0_15 · Cited by 5
Cited by
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Self-citationEASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Self-citationAASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2018) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,070
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Self-citation
Metadata
- Authors
- Bruix, J., Llovet, J. M., Castells, A., Montañá, X., Brú, C., Ayuso, M. D. C., Vilana, R., & Rodés, J.
- Venue
- Hepatology
- Published
- 1998-06
- Volume
- 27
- Issue
- 6
- Pages
- 1578-1583
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2074333538
- Cited by
- 533
- References
- 22
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.